Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
Reconstitution volumes and diluent choice for investigational peptides are specified in the trial protocol and IMPD they are not appropriate for individual self-use
Liraglutide for managing overweight and obesity TA664
Although the peptide is reported to be stable in gastric juice, its bioavailability may be lower with this route
The peptide's 15-amino-acid structure makes direct CYP active-site binding less likely than with small-molecule drugs, but peptide fragments can still influence enzyme expression through downstream signaling
(2) Malinda KM, Sidhu GS, Mani H, Banaudha K, Maheshwari RK, Goldstein AL, Kleinman HK
US$ 21.36
US$ 25.70
US$ 25.32
